Stockreport

Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata Transcript [Seeking Alpha]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Company Participants Vivian Wu - Investor Relations Howard W. Robin - CEO, President & Director Jonathan Zalevsky - Senior VP and Chief Research & Development Off [Read more]